Return to search

DARA Biosciences Doing Reverse Merger

DARA Biosciences Inc. has agreed to go public via a reverse merger with Point Therapeutics Inc. (Nasdaq: POTP), following which DARA shareholders would hold 96.4% of Point's outstanding shares. The merged company will retain the DARA Biosciences name. DARA is a Raleigh, N.C.-based drug company that has raised just over $10 million in VC funding from Clayton Associates and Waveland Capital. www.darabiosciences.com